Basel Biometric Section of the Austro-Swiss Region of the International Biometric Society
Agenda BBS Seminar Bayesian Methods in Adaptive Dose-Finding Trials PDF
This BBS seminar takes place on Monday 13 April 2015 15:30-17:00.
Location: Auditorium of the Roche Learning Center, Aeschenvorstadt 56, 4051 Basel, Switzerland
Agenda Joint BBS-EFSPI Seminar Data Sharing in Clinical Development PDF
This joint BBS-EFSPI seminar takes place on Thursday 13 November 2014 9:15-15:30.
Location: Actelion Pharmaceuticals, Hegenheimermattweg 95, 4123 Allschwil, Switzerland PDF
Sabine Atzor, Clinical Trial Data Transparency – Environment & Expectations
Stefan Driessen, EFSPI position on EMA policy on publication of clinical data
Franz König, Big thunder, little rain?
Rebecca Sudlow, Overview of Data Sharing Initiatives in Industry and Current Experiences
Janice Branson, Practicalities of accessing and using data – Advice for Researchers
Sally Hollis, Considerations for analysis plans for data sharing requests
Katherine Tucker, Principles to maintain patient confidentiality
Guilliaume Breton, Patient Confidentiality Implementation
Agenda BBS Seminar Meta-Analysis of Clinical Safety Data PDF
This BBS seminar takes place on Thursday 2 October 2014 8:30-13:00.
Location: Bildungszentrum 21, Missionsstrasse 21, 4003 Basel, Switzerland
Stephen Evans, Do meta-analyses of adverse events have adverse effects?
Brenda Crowe, Comparison of Bayesian and Frequentist Meta-Analytical Approaches for Analyzing Time to Event Data
Michael Gaffney, Model Selection in Meta‐Analysis of Clinical Safety Data – Fixed or Random Study Effect
Amy Xia, Bayesian Meta-Analysis in Drug Safety Evaluation
Jim Slattery, Meta-analysis in EU regulation
Tarek A. Hammad, Sources of Bias in Meta-analysis of RCTs
Mark Levenson, Meta‐Analysis for Safety: Context and Examples at US FDA
Workshop of the joint working group “Adaptive Designs and Multiple Testing Procedures” of the German Region (DR) and the Basel Biometric Section (BBS) of the Austro-Swiss (ROeS) Region of the International Biometric Society (IBS) PDF
Novartis Learning Center Horburg, Müllheimerstrasse 195, 4057 Basel, Switzerland (Map of the workshop venue PDF).
Agenda BBS Seminar Applications for statisticians working with “Real-World Data” PDF
This BBS seminar is scheduled for Wednesday 7 May 2014 16:00-17:30.
Location: Biozentrum, University of Basel, Hörsaal 106, Klingelbergstrasse 50/70, 4056 Basel, Switzerland
Pamela Landsman-Blumberg, Applications for statisticians working with “Real-World Data”
This BBS meeting is scheduled for Tuesday 4 February 2014 16:00-17:30.
Location: Auditorium of the Roche Learning Center, Aeschenvorstadt 56, 4051 Basel
Willi Sauerbrei, Patrick Royston, Benjamin Kasenda and Matthias Briel, A method for IPD meta-analysis of treatment-covariate interaction with a continuous predictor in randomised trials
Willi Sauerbrei and Patrick Royston, Towards stratified medicine – instead of dichotomization, estimate a treatment effect function for a continuous covariate
Willi Sauerbrei and Patrick Royston, A new strategy for meta-analysis of continuous covariates in observational studies with IPD
European Statistical Meeting Health Technology Assessment
Fred Sorenson, Health Technology Assessment – Why is it so important?
Matthias Egger and Mike Chambers, Moving HTA forward: The challenges of incorporating real world evidence into Health Technology Assessment
Mike Chambers and Matthias Egger, GetReal: Clinical effectiveness in drug development
Claudia Nicolay, Health Technology Assessment – What’s in for Stats?
Jens Grüger, HTA and personalized healthcare
Skip Olson, HTA – Use of observational, retrospective or prospective studies
Bruno Falissard, The place of subjectivity in the French system (HAS): a good thing or an archaism?
Ralf Bender, Biometrical topics of Health Technology Assessment in Germany
Friedhelm Leverkus, 30 Months AMNOG Health Technology Assessment: Outcomes and Issues
Lou Garrison, HTA in Emerging Markets: A Framework and Examples
Richard Nixon, Using early health economic models to support drug development decisions
Chrissie Fletcher, Using indirect treatment comparisons to support an HTA